Lyophilization Technology Revenue and Competitors
Estimated Revenue & Valuation
- Lyophilization Technology's estimated annual revenue is currently $8.8M per year.
- Lyophilization Technology's estimated revenue per employee is $201,000
Employee Data
- Lyophilization Technology has 44 Employees.
- Lyophilization Technology grew their employee count by 7% last year.
Lyophilization Technology's People
Name | Title | Email/Phone |
---|
Lyophilization Technology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Lyophilization Technology?
Lyophilization Technology, Inc. is a unique Technical Service and Contract Development and Manufacturing Organization. LTI provides comprehensive in-house capabilities ranging from thermal analysis, product design, formulation development, process engineering, streamlining operations, improving compliance, preclinical to Phase II clinical material preparation and technical support for a wide variety of products. LTI has successfully developed formulations, manufacturing processes and prepared material for clinical trials for a wide variety of products. • Anti-infectives • Biologics / Vaccines • Oncolytics / HPCs • Small Molecules / Therapeutics Development Services are conducted with product quality and a manufacturing mindset from the start, considering product administration, stability and processing requirements. Distinct processing areas are comprised of ISO 5 clean rooms directly linked to pilot-scale lyophilizers. Clinical Manufacturing Area (CMA) is flexible for preparation of products with unique requirements, adheres to aggressive project timelines, and is fully cGMP compliant. • Pre-clinical to Phase II Clinical Material • Dedicated / disposable product contact items/equipment • Combined aseptic processing with product containment • Vials 2 to 100 mL and novel delivery systems • US / EU complaint Technical Services The broad range of experience in a wide variety of products provides a specialized expertise from which you can capitalize.
keywords:N/AN/A
Total Funding
44
Number of Employees
$8.8M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.5M | 44 | 7% | N/A |
#2 | $12M | 53 | -5% | N/A |
#3 | $12.8M | 58 | 14% | N/A |
#4 | $17M | 60 | -5% | $14.3M |
#5 | $20M | 63 | 5% | N/A |